Detalles de la búsqueda
1.
[Carcinoma, tuberculosis, atypical pneumonia - or may be pulmonary tularemia? Two case reports]. / Karzinom, Tuberkulose, atypische Pneumonie oder vielleicht pulmonale Tularämie? Zwei Fallberichte.
Pneumologie
; 78(3): 199-203, 2024 Mar.
Artículo
en Alemán
| MEDLINE | ID: mdl-37857320
2.
Experience with afatinib in patients with non-small cell lung cancer progressing after clinical benefit from gefitinib and erlotinib.
Oncologist
; 19(10): 1100-9, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25232040
3.
Primary pulmonary synovial sarcoma: a rare primary pulmonary tumor.
Lung
; 192(1): 211-4, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24170216
4.
A randomized, multicenter phase II study comparing efficacy, safety and tolerability of two dosing regimens of cisplatin and pemetrexed in patients with advanced or metastatic non-small-cell lung cancer.
Ther Adv Med Oncol
; 13: 1758835921996506, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34104223
5.
A Randomized-Controlled Phase 2 Study of the MET Antibody Emibetuzumab in Combination with Erlotinib as First-Line Treatment for EGFR Mutation-Positive NSCLC Patients.
J Thorac Oncol
; 15(1): 80-90, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31622732
6.
Clinical Experience of Immunotherapy Treatment: Efficacy and Toxicity Analysis of the Compassionate Use Program of Nivolumab in Patients with Advanced Squamous Cell Non-Small Cell Lung Cancer.
Oncol Res Treat
; 42(5): 243-255, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30995666
7.
Efficacy and safety analysis of the German expanded access program of osimertinib in patients with advanced, T790M-positive non-small cell lung cancer.
J Cancer Res Clin Oncol
; 144(12): 2457-2463, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30244389
8.
Efficacy and Safety of Ramucirumab With Docetaxel Versus Placebo With Docetaxel as Second-Line Treatment of Advanced Non-Small-Cell Lung Cancer: A Subgroup Analysis According to Patient Age in the REVEL Trial.
Clin Lung Cancer
; 19(3): 270-279.e3, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29373274
9.
Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE).
J Clin Oncol
; 33(35): 4194-201, 2015 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-26527789
10.
Phase II trial of a trimodality regimen for stage III non-small-cell lung cancer using chemotherapy as induction treatment with concurrent hyperfractionated chemoradiation with carboplatin and paclitaxel followed by subsequent resection: a single-center study.
J Clin Oncol
; 28(6): 942-8, 2010 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-20100967
Resultados
1 -
10
de 10
1
Próxima >
>>